Yuko Wakayama

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

T. Hibi, Y. Abe, H. Yagi, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus

T. Hibi, H. Saito, H. Ebinuma, 2014, PloS one.

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C

T. Hibi, H. Saito, H. Ebinuma, 2015, PloS one.